Skip to main content
SpringerLink
Log in

Current Management of Ocular Surface Squamous Neoplasia (OSSN)

  • Chapter
  • First Online:
Ocular Oncology

Part of the book series: Current Practices in Ophthalmology ((CUPROP))

  • 367 Accesses

Abstract

Ocular surface squamous neoplasia (OSSN) is a superficial conjunctival and cornea tumor but 3–9% can have intraocular invasion and approximately 1–6% can have orbital invasion. Primary treatment remains surgical but use of topical chemotherapy has greatly improved the outcome for extensive lesions and for recurrent tumors. Radiation and enucleation or exenteration are reserved for extensive lesions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Lee GA, Hirst LW. Ocular surface squamous neoplasia. Surv Ophthalmol. 1995;39:429–50.

    Article  CAS  PubMed  Google Scholar 

  2. Basti S, Macsai MS. Ocular surface squamous neoplasia: a review. Cornea. 2003;22:687–704.

    Article  PubMed  Google Scholar 

  3. Tananuvat N, Lertprasertsuke N. Ocular surface squamous neoplasia. In: Srivastava S. Intraepithelial neoplasia; 2012. ISBN: 978–953–307-987-5. InTech. http://www.intechopen.com/books/intraepithelial-neoplasia/ocular-surface-squamous-neoplasia. Accessed 20 Jul 2017.

  4. Sepulveda R, Pe’er J, Midena E, et al. Topical chemotherapy for ocular surface squamous neoplasia: current status. Br J Ophthalmol. 2010;94:532–5.

    Article  PubMed  Google Scholar 

  5. Frucht-Pery J, Rozenman Y. Mitomycin C therapy for corneal intraepithelial neoplasia. Am J Ophthalmol. 1994;117(2):164–8.

    Article  CAS  PubMed  Google Scholar 

  6. Verweij J, Pinedo HM. Mitomycin C: mechanism of action, usefulness and limitations. Anti-Cancer Drugs. 1990;1:5e13.

    Article  Google Scholar 

  7. Shields CL, Demirci H, Marr BP, et al. Chemoreduction with topical mitomycin C prior to resection of extensive squamous cell carcinoma of the conjunctiva. Arch Ophthalmol. 2005;123:109–13.

    Article  PubMed  Google Scholar 

  8. Gupta A, Muecke J. Treatment of ocular surface squamous neoplasia with mitomycin C. Br J Ophthalmol. 2010;94:555–8.

    Article  CAS  PubMed  Google Scholar 

  9. Besley J, Pappalardo J, Lee GA, et al. Risk factors for ocular surface squamous neoplasia recurrence after treatment with topical mitomycin C and interferon alpha-2b. Am J Ophthalmol. 2014;157(2):287–93.

    Article  CAS  PubMed  Google Scholar 

  10. Rozenman Y, Frucht-Pery J. Treatment of conjunctival intraepithelial neoplasia with topical drops of mitomycin C. Cornea. 2000;19:1–6.

    Article  CAS  PubMed  Google Scholar 

  11. Prabhasawat P, Tarinvorakup P, Tesavibul N, et al. Topical 0.002% mitomycin C for the treatment of conjunctival-corneal intraepithelial neoplasia and squamous cell carcinoma. Cornea. 2005;24:443–8.

    Article  PubMed  Google Scholar 

  12. Russell HC, Chadha V, Lockington D, Kemp EG. Topical mitomycin C chemotherapy in the management of ocular surface neoplasia: a 10-year review of treatment outcomes and complications. Br J Ophthalmol. 2010;94(10):1316–21.

    Article  CAS  PubMed  Google Scholar 

  13. Ramasubramanian A, Shields CL, Sinha N, Shields JA. Ocular surface squamous neoplasia after corneal graft. Am J Ophthalmol. 2010;149(1):62–5.

    Article  PubMed  Google Scholar 

  14. Wilson MW, Hungerford JL, George SM, et al. Topical mitomycin C for the treatment of conjunctival and corneal epithelial dysplasia and neoplasia. Am J Ophthalmol. 1997;124:303–11.

    Article  CAS  PubMed  Google Scholar 

  15. Frucht-Pery J, Rozenman Y, Pe’er J. Topical mitomycin-C for partially excised conjunctival squamous cell carcinoma. Ophthalmology. 2002;109:548–52.

    Article  PubMed  Google Scholar 

  16. Shields CL, Naseripour M, Shields JA, et al. Topical mitomycin C for extensive, recurrent conjunctival-corneal squamous cell carcinoma. Am J Ophthalmol. 2002;133:601–6.

    Article  CAS  PubMed  Google Scholar 

  17. Chen C, Louis D, Dodd T, et al. Mitomycin C as an adjunct in the treatment of localised ocular surface squamous neoplasia. Br J Ophthalmol. 2004;88:17–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Birkholz ES, Goins KM, Sutphin JE, Kitzmann AS, Wagoner MD. Treatment of ocular surface squamous cell intraepithelial neoplasia with and without mitomycin C. Cornea. 2011;30(1):37–41.

    Article  PubMed  Google Scholar 

  19. Rudkin AK, Dempster L, Muecke JS. Management of diffuse ocular surface squamous neoplasia: efficacy and complications of topical chemotherapy. Clin Exp Ophthalmol. 2015;43(1):20–5.

    Article  PubMed  Google Scholar 

  20. Özcan AA, Çiloğlu E, Esen E, Şimdivar GH. Use of topical bevacizumab for conjunctival intraepithelial neoplasia. Cornea. 2014;33:1205–9.

    Article  PubMed  Google Scholar 

  21. McKelvie PA, Daniell M. Impression cytology following mitomycin C therapy for ocular surface squamous neoplasia. Br J Ophthalmol. 2001;85:1115–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. de Keizer RJW, de Wolff-Rouendall D, van Delft JL. Topical application of 5-fluorouracil in premalignant lesions of cornea, conjunctiva and eyelid. Doc Ophthalmol. 1986;64:31–42.

    Article  PubMed  Google Scholar 

  23. Yeatts RP, Engelbrecht NE, Curry CD, et al. 5-Fluorouracil for the treatment of intraepithelial neoplasia of the conjunctiva and cornea. Ophthalmology. 2000;107:2190–5.

    Article  CAS  PubMed  Google Scholar 

  24. Yeatts RP, Ford JG, Stanton CA, et al. Topical 5-fluorouracil in treating epithelial neoplasia of the conjunctival and cornea. Ophthalmology. 1995;102:1338–44.

    Article  CAS  PubMed  Google Scholar 

  25. Midena E, Degli Angeli C, Valenti M, de Belvis V, Boccato P. Treatment of conjunctival squamous cell carcinoma with topical 5-fluorouracil. Br J Ophthalmol. 2000;84:268–72.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Rudkin AK, Muecke JS. Adjuvant 5-fluorouracil in the treatment of localised ocular surface squamous neoplasia. Br J Ophthalmol. 2011;95:947–50.

    Article  PubMed  Google Scholar 

  27. Parrozzani R, Frizziero L, Trainiti S, et al. Topical 1% 5-fluorouracil as a sole treatment of corneoconjunctival ocular surface squamous neoplasia: long-term study. Br J Ophthalmol. 2017;101:1094–9.

    Article  PubMed  Google Scholar 

  28. Parrozzani R, Lazzarini D, Alemany-Rubio E, et al. Topical 1% 5-fluorouracil in ocular surface squamous neoplasia: a long-term safety study. Br J Ophthalmol. 2011;95:355–9. https://doi.org/10.1136/bjo.2010.183244.

    Article  PubMed  Google Scholar 

  29. Joag MG, Sise A, Murillo JC, et al. Topical 5-fluorouracil 1% as primary treatment for ocular surface squamous neoplasia. Ophthalmology. 2016;123(7):1442–8.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Maskin SL. Regression of limbal epithelial dysplasia with topical interferon. Arch Ophthalmol. 1994;112:1145–6.

    Article  CAS  PubMed  Google Scholar 

  31. Kim J, Modlin RL, Moy RL, Dubinett SM, McHugh T, Nickoloff BJ, Uyemura K. IL-10 production in cutaneous basal and squamous cell carcinomas. A mechanism for evading the local T cell immune response. J Immunol. 1995;155(4):2240–7.

    CAS  PubMed  Google Scholar 

  32. Karp CL, Galor A, Chhabra S, Barnes SD, Alfonso EC. Subconjunctival/perilesional recombinant interferon α2b for ocular surface squamous neoplasia: a 10-year review. Ophthalmology. 2010;117(12):2241–6.

    Article  PubMed  Google Scholar 

  33. Vann RR, Karp CL. Perilesional and topical interferon alfa-2b for conjunctival and corneal neoplasia. Ophthalmology. 1999;106:91–7.

    Article  CAS  PubMed  Google Scholar 

  34. Karp CL, Moore JK, Rosa RH. Treatment of conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b. Ophthalmology. 2001;108:1093–8.

    Article  CAS  PubMed  Google Scholar 

  35. Boehm MD, Huang AJ. Treatment of recurrent corneal and conjunctival intraepithelial neoplasia with topical interferon alpha-2b. Ophthalmology. 2004;111:1755–61.

    Article  PubMed  Google Scholar 

  36. Galor A, Karp CL, Chhabra S, et al. Topical interferon alpha 2b eye-drops for treatment of ocular surface squamous neoplasia: a dose comparison study. Br J Ophthalmol. 2010;94:551–4.

    Article  CAS  PubMed  Google Scholar 

  37. Schechter BA, Koreishi AF, Karp CL, Feuer W. Long-term follow-up of conjunctival and corneal intraepithelial neoplasia treated with topical interferon alfa-2b. Ophthalmology. 2008;115:1291–l6.

    Article  PubMed  Google Scholar 

  38. Nanji AA, Sayyad FE, Karp CL. Topical chemotherapy for ocular surface squamous neoplasia. Curr Opin Ophthalmol. 2013;24:336–42.

    Article  PubMed  Google Scholar 

  39. Faramarzi A, Feizi S. Subconjunctival bevacizumab injection for ocular surface squamous neoplasia. Cornea. 2013;32:998–1001.

    Article  PubMed  Google Scholar 

  40. Paul S, Stone DU. Intralesional bevacizumab use for invasive ocular surface squamous neoplasia. J Ocul Pharmacol Ther. 2012;28:647–9.

    Article  CAS  PubMed  Google Scholar 

  41. Asena L, Dursun Altinors D. Topical Nevacizumab for the treatment of ocular surface squamous neoplasia. J Ocul Pharmacol Ther. 2015;31(8):487–90.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Finger PT, Chin KJ. Refractory squamous cell carcinoma of the conjunctiva treated with subconjunctival ranibizumab (Lucentis): a two-year study. Ophthal Plast Reconstr Surg. 2012;28:85–9.

    Article  PubMed  Google Scholar 

  43. Adler E, Turner JR, Stone DU. Ocular surface squamous neoplasia: a survey of changes in the standard of care from 2003 to 2012. Cornea. 2013;32:1558–61.

    Article  PubMed  Google Scholar 

  44. Arepalli S, Kaliki S, Shields CL, et al. Plaque radiotherapy in the management of scleral-invasive conjunctival squamous cell carcinoma: an analysis of 15 eyes. JAMA Ophthalmol. 2014;132:691–6.

    Article  PubMed  Google Scholar 

  45. Shields JA, Shields CL, DePotter P. Surgical management of conjunctival tumors. Arch Ophthalmol. 1997;115:808–15.

    Article  CAS  PubMed  Google Scholar 

  46. Sudesh S, Rapuano CJ, Cohen EJ, Eagle RC Jr, Laibson PR. Surgical management of ocular surface squamous neoplasms: the experience from a cornea center. Cornea. 2000;19(3):278–83.

    Article  CAS  PubMed  Google Scholar 

  47. Palamar M, Kaya E, Egrilmez S, Akalin T, Yagci A. Amniotic membrane transplantation in surgical management of ocular surface squamous neoplasias: long-term results. Eye. 2014;28(9):1131–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Cha SB, Shields CL, Shields JA, Eagel RC Jr, De Potter P, Talansky M. Massive precorneal extension of squamous cell carcinoma of the conjunctiva. Cornea. 1993;12(6):537–40.

    Article  CAS  PubMed  Google Scholar 

  49. Pizzarello LD, Jacobiec FA. Bowen’s disease of the conjunctiva: a misnomer. In: Jacobiec FA, editor. Ocular and adnexal tumors. Birmingham, AL: Aesculapius; 1978. p. 553–71.

    Google Scholar 

  50. Erie JC, Campbell RJ, Liesegang TJ. Conjunctival and corneal intraepithelial and invasive neoplasia. Ophthalmology. 1986;93:176–83.

    Article  CAS  PubMed  Google Scholar 

  51. Li AS, et al. Recurrence of ocular surface squamous neoplasia treated with excisional biopsy and cryotherapy. Am J Ophthalmol. 2015;160(2):213–219.e1.

    Article  PubMed  Google Scholar 

  52. Siedlecki AN, Tapp S, Tosteson ANA, et al. Surgical versus interferon alpha-2b treatment strategies for ocular surface squamous neoplasia: a literature-based decision analysis. Cornea. 2016;35(5):613–8.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Tabin G, Levin S, Snibson G, et al. Late recurrences and the necessity for long-term follow-up in corneal and conjunctival intraepithelial neoplasia. Ophthalmology. 1997;104:485–92.

    Article  CAS  PubMed  Google Scholar 

  54. Philipp W, Daxecker F, Langmayr J, Gottinger W. Spontaneous corneal rupture after strontium irradiation of a conjunctival squamous cell carcinoma. Ophthalmologica. 1987;195:113–8.

    Article  CAS  PubMed  Google Scholar 

  55. Lommatzsch P. Beta-ray treatment of malignant epithelial tumors of the conjunctiva. Am J Ophthalmol. 1976;81:198–206.

    Article  CAS  PubMed  Google Scholar 

  56. Kearsley JH, Fitchew RS, Taylor RG. Adjunctive radiotherapy with strontium-90 in the treatment of conjunctival squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 1988;14(3):435–43.

    Article  CAS  PubMed  Google Scholar 

  57. Lui H, Hobbs L, Tope WD, Lee PK, Elmets C, Provost N, Chan A, Neyndorff H, Su XY, Jain H, Hamzavi I, McLean D, Bissonnette R. Photodynamic therapy of multiple nonmelanoma skin cancers with verteporfin and red light-emitting diodes: two-year results evaluating tumor response and cosmetic outcomes. Arch Dermatol. 2004;140(1):26–32.

    Article  CAS  PubMed  Google Scholar 

  58. Barbazetto IA, Lee TC, Abramson DH. Treatment of conjunctival squamous cell carcinoma with photodynamic therapy. Am J Ophthalmol. 2004;138(2):183–9.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Louisville Ophthalmology, Louisville, KY, USA

    S. Madison Duff, Niloofar Piri & Hossein Asghari

Authors
  1. S. Madison Duff
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Niloofar Piri
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hossein Asghari
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hossein Asghari .

Editor information

Editors and Affiliations

  1. University of Louisville, Louisville, KY, USA

    Aparna Ramasubramanian

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Duff, S.M., Piri, N., Asghari, H. (2019). Current Management of Ocular Surface Squamous Neoplasia (OSSN). In: Ramasubramanian, A. (eds) Ocular Oncology . Current Practices in Ophthalmology. Springer, Singapore. https://doi.org/10.1007/978-981-13-7538-5_5

Download citation

  • DOI: https://doi.org/10.1007/978-981-13-7538-5_5

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-13-7537-8

  • Online ISBN: 978-981-13-7538-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation